DJ Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 2.29% to $1.28 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.42% to 27,086.81 and the Dow Jones Industrial Average rising 0.09% to 51,078.88.
The stock's fall snapped a two-day winning streak.
Inovio Pharmaceuticals Inc. closed 57.03% short of its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.81% to $223.51, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 2.10% to $25.63.
Trading volume (1.7 M) remained 1.3 million below its 50-day average volume of 3.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 01, 2026 17:24 ET (21:24 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments